Taken together, available data suggest that many patients with CTEPH have either inherited or acquired defects in VEGF signaling, although it is clear neither VEGF’s action nor its disruption is the sole mediator of either the normal angiogenic response or progression to PH, respectively. Here, VEGFA is linked to chronic thromboembolic pulmonary hypertension.